Contract 75N91025P00437
Invivoscribe, Inc. · Department Of Health And Human Services · July 8, 2025
Invivoscribe, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 8, 2025 for $18,000 of work in in-vitro diagnostic substance manufacturing. Performance is in San Diego, CA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 10, 2025.
Contract details
- PIID
- 75N91025P00437
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- San Diego, CA
- First action
- July 8, 2025
- Latest action
- July 10, 2025
Description
BIOLOGICAL KIT
Modification timeline
-
July 10, 2025Mod P00001 · Funding Only Action$18.3K
-
July 8, 2025Base award$18.4K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91025P00437?
Contract 75N91025P00437 is a federal contract awarded to Invivoscribe, Inc. by Department Of Health And Human Services on July 8, 2025 for $18,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75N91025P00437?
Invivoscribe, Inc. won contract 75N91025P00437 from Department Of Health And Human Services.
How much is contract 75N91025P00437 worth?
Contract 75N91025P00437 has obligated $18,000 to date.